Table 2.
Association between MMP-2 expression and clinic-pathological parameters
| MMP-2 | Score 0 | Score 1 | Score 2 | Score 3 | p |
|---|---|---|---|---|---|
| Age (years) | |||||
| Mean ± SD | 46.56±15.594 | 51.18±11.98 | 46.3311±11.6 | 52.25±11.25 | 0.537 |
| Gender (%) | |||||
| Male | 10 (33.33%) | 8 (26.67%) | 7 (23.33%) | 5 (16.67%) | |
| Female | 15 (50%) | 3 (10%) | 5 (16.67%) | 7 (23.33%) | 0.296 |
| Sites (%) | |||||
| Tongue | 10 (38.46%) | 5 (19.23%) | 5 (19.23%) | 6 (23.08%) | |
| Buccal and/or labial | 14 (43.75%) | 5 (15.63%) | 7 (21.88%) | 6 (18.75%) | 0.96 |
| Others | 1 (50%) | 1 (50%) | 0 | 0 | |
| Parameters | |||||
| Oral mucosa (%) | 13 (65%) | 2 (10%) | 3 (15%) | 2 (10%) | |
| Epithelial hyperplasia (%) | 10 (50%) | 4 (20%) | 3 (15%) | 3 (15%) | 0.136 |
| Epithelial dysplasia (%) | 4 (20%) | 4 (20%) | 5 (25%) | 7 (35%) |